×

Health Care Equipment and Supplies Health Care Equipment

  • BERLIN— A German federal court has rejected a claim from a woman who received leak-prone breast implants for compensation from a German product-testing company. Thursday's ruling from Germany's Federal Court of Justice follows a similar decision two years ago by a French appeals court. The plaintiff received the implants in 2008 in Germany but had them...

  • *Group of U.S. lawmakers calls India policy "dangerous". NEW DELHI, June 19- A group of U.S. lawmakers has backed medical device makers by urging India to reconsider its decision to cap prices of heart stents, raising the issue ahead of Prime Minister Narendra Modi's visit to the United States later this week. In a letter sent to the Indian ambassador to Washington last...

  • CHICAGO— It sounds futuristic: drones carrying heart defibrillators swooping in to help bystanders revive people stricken by cardiac arrest. This is a crisis and it's time we do something different to address it, "said Yancy, cardiology chief at Northwestern University's medical school in Chicago. The researchers reached the same conclusion after analyzing...

  • NEW DELHI/ MUMBAI, June 7- India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for price controls to reduce costs to patients, which if agreed could be another blow to the country's $5 billion- a-year medical-technology industry. The National Pharmaceutical Pricing Authority had said it...

  • Carlos Varas, a Miami-Dade County mosquito control inspector, walks through the streets looking for places that might hold breeding mosquitos that are carrying the Zika virus on September 2, 2016 in Miami Beach, Florida.

    Most countries are not adequately prepared for another infectious disease outbreak, according to new research.

  • The da Vinci robotic system.

    Goldman initiates coverage on Intuitive Surgical with a buy rating because robot-assisted procedures will double in the next two years.

  • *AstraZeneca sets durvalumab price at $15,000/ month. Leerink analyst Seamus Fernandez sees durvalumab capturing a modest 10 percent of the estimated $2.3 billion global bladder cancer market, while AstraZeneca in 2014 put the drug's peak sales in all cancers at $6.5 billion, including combination use. The U.S. Food and Drug Administration said late on Monday...

  • *AstraZeneca sets durvalumab price at $15,000/ month. May 1- U.S. regulators have approved AstraZeneca's key immunotherapy drug durvalumab as a treatment for bladder cancer, marking the first commercial green light for a product the company hopes will go on to sell billions of dollars. The U.S. Food and Drug Administration said on Monday it granted accelerated...

  • May 1- The U.S. Food and Drug Administration on Monday granted accelerated approval to AstraZeneca Plc's immuno-oncology drug to treat a type of bladder cancer in patients whose disease progressed despite chemotherapy. The FDA also approved a complementary diagnostic from Roche Holding AG to assess whether the PD-L1 protein is expressed in urothelial...

  • WASHINGTON, April 25- Four years ago, two analysts who liked to swap notes on numbers they thought looked odd took a fateful step and tipped off U.S. regulators about a company that one of them had watched for months. Orthofix International NV caught one of the analysts' attention in 2012. The Texas- based medical device maker kept hitting ambitious earnings targets...

  • WASHINGTON, April 25- Four years ago, two analysts who liked to swap notes on numbers they thought looked odd took a fateful step and tipped off U.S. regulators about a company that one of them had watched for months. Orthofix International NV caught one of the analysts' attention in 2012. The Texas- based medical device maker kept hitting ambitious earnings targets...

  • The Hylarana malabarica frog, similar to the Hydrophylax bahuvistara frog.

    NBC news reports that a compound found in the protective slime of an Indian frog might become a powerful new drug to treat the flu, according to research.

  • April 18- U.S. drug distributor Cardinal Health Inc agreed to buy medical device maker Medtronic Plc's medical supplies units for $6.1 billion and said it expected full-year adjusted earnings at the lower end of its forecast. Cardinal Health, which had forecast adjusted profit in the range of $5.35- $5.50 per share, blamed generic price deflation for the...

  • April 18- U.S. drug distributor Cardinal Health Inc said on Tuesday it would buy medical device maker Medtronic Plc's medical supplies businesses for $6.1 billion in cash. Cardinal Health is acquiring the patient care, deep vein thrombosis and nutritional insufficiency units from Medtronic. Cardinal Health said it would finance the acquisition with cash...

  • The FDA, which said the company failed to disclose at least one death associated with one of the devices, said an inspection of the company's facility in Sylmar, California, raised questions about the safety of several implantable defibrillators and its Merlinzhome monitor, which allows doctors to care remotely for patients with cardiac devices.

  • April 12- Medical device maker Hologic Inc has been hit with a lawsuit alleging its product for treating heavy menstrual bleeding infringes patented technology developed by start-up Minerva Surgical Inc, court papers show. The product was launched in Europe, Canada and Australia in 2016.. Its backers include the venture capital firms New Enterprise...

  • April 9- Shares of Glaukos Corp could fall 30 percent in the next year, as years of success by the medical device maker has attracted competition from larger companies that threaten its market share, according to the April 10 edition of Barron's. Glaukos shares have risen 150 percent to around $50 since June 2015, trading at 300 times expected earnings and 10 times...

  • Protesters demonstrate against President Donald Trump and his plans to end Obamacare outside the White House in Washington, March 23, 2017.

    "Huge shocks from the political system are always a distraction," athenahealth's Jonathan Bush told CNBC.

  • This sock could save your infant's life

    Owlet is out with Smart Sock 2, an updated version of the original, that seamlessly monitors your baby's breathing and vitals after leaving the hospital in the comfort of your home.

  • March 30- Boston Scientific Corp on Thursday agreed to buy Swiss medical device maker Symetis SA for $435 million, looking to bolster its presence in Europe after recalling a range of heart valves in the region. The company's Acurate systems will broaden Boston Scientific's TAVR range to include additional designs and delivery methods that cover more...